Ellen Price, DO
Pain Medicine · Fruita, CONPI 1982684247
Payments from drug & device makers
What this record shows
AbbVie accounts for 75.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $2,474 and has fallen 93.3% since, to $167 in 2025.
Across 64 payments — averaging $65.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Medtronic$233
- Saluda Medical Americas, Inc.$189
- Boston Scientific$157
- Abbott$140
- Pfizer$57
- plus $247 from 8 others
What the payments were for
- Speaking & faculty fees$2,40057%
- Food & beverage$1,80143%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $3,178 |
| Medtronic(2 entities) | 2 | $233 |
| Saluda Medical Americas, Inc. | 1 | $189 |
| Boston Scientific | 3 | $157 |
| Abbott | 1 | $140 |
| Pfizer | 3 | $57 |
| Novartis | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Lilly USA, LLC | 3 | $42 |
| Merz Pharmaceuticals, LLC | 2 | $37 |
| Biodelivery Sciences International, Inc. | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Amgen | 1 | $16 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,201 in reported general payments places this provider in the 60th percentile of 96 pain medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 13 | $11,349 |
| Xtampza ErOxycodone Myristate | 19 | $5,972 |
| Buprenorphine | 20 | $5,550 |
| VascepaIcosapent Ethyl | 11 | $3,928 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $1,787 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $1,251 |
| Duloxetine Hcl | 61 | $716 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $630 |
| Pregabalin | 35 | $513 |
| Celecoxib | 21 | $480 |
| Lidocaine | 11 | $447 |
| Bupropion XlBupropion Hcl | 28 | $301 |
| Tizanidine Hcl | 75 | $287 |
| Tramadol Hcl | 49 | $207 |
| Ropinirole Hcl | 11 | $178 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Fruita
- Kyle ChristophersonFruita$10K
- Robert MoghimGolden$273K
- Jack RentzGreenwood Village$264K
- Donald BernardiniEnglewood$102K
- Haley BurkeAurora$55K
- Amar PatelThornton$47K
- David ColumbusLoveland$30K
- Matthew PouliotFort Collins$26K
- Justin MerkowEnglewood$24K
- Daniel FeldmanBroomfield$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.